Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

by Michel Morris,Johns Hopkins UniversityDiabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health.

Updated on: April 08,2026

Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

by Michel Morris,Johns Hopkins UniversityDiabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health.

Updated on:April 08,2026

Why Some People Get Bad Colds and Others Don’t

Updated on: January 22,2026

Why Some People Get Bad Colds and Others Don’t

Updated on:January 22,2026

Self-reactive T cells may explain why some patients can't reach undetectable HIV levels

byDelthia Ricks, Medical XpressCredit: CC0 Public DomainDespite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human immunodeficiency virus

Updated on: January 18,2026

Self-reactive T cells may explain why some patients can't reach undetectable HIV levels

byDelthia Ricks, Medical XpressCredit: CC0 Public DomainDespite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human immunodeficiency virus

Updated on:January 18,2026

Real-world data gives Africa a smarter path to fighting HIV and TB

byWits UniversityCredit: Unsplash/CC0 Public DomainHIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment interventions are actually working

Updated on: January 08,2026

Real-world data gives Africa a smarter path to fighting HIV and TB

byWits UniversityCredit: Unsplash/CC0 Public DomainHIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment interventions are actually working

Updated on:January 08,2026

Rare tissue samples reveal where HIV hides in different parts of body

by Jeff Renaud,University of Western OntarioHIV-1 LTR heterogeneity at the TBC1D5 integration site hotspot. Credit:Communications Medicine(2025). DOI: 10.1038/s43856-025-01146-5Researchers at Western

Updated on: January 07,2026

Rare tissue samples reveal where HIV hides in different parts of body

by Jeff Renaud,University of Western OntarioHIV-1 LTR heterogeneity at the TBC1D5 integration site hotspot. Credit:Communications Medicine(2025). DOI: 10.1038/s43856-025-01146-5Researchers at Western

Updated on:January 07,2026

Low-dose THC may reduce side effects of HIV treatment

byTexas Biomedical Research InstituteThe number of active serotonin receptors (green) were dramatically increased in the lining of the gut following treatment with low-dose THC, which helps increase s

Updated on: December 30,2025

Low-dose THC may reduce side effects of HIV treatment

byTexas Biomedical Research InstituteThe number of active serotonin receptors (green) were dramatically increased in the lining of the gut following treatment with low-dose THC, which helps increase s

Updated on:December 30,2025

Antibody discovered that blocks almost all known HIV variants in neutralization assays

by Eva Schissler,University of CologneUltralong 11-amino-acid insertion facilitates the quaternary binding mode of 04_A06. Credit:Nature Immunology(2025). DOI: 10.1038/s41590-025-02286-5An internation

Updated on: December 26,2025

Antibody discovered that blocks almost all known HIV variants in neutralization assays

by Eva Schissler,University of CologneUltralong 11-amino-acid insertion facilitates the quaternary binding mode of 04_A06. Credit:Nature Immunology(2025). DOI: 10.1038/s41590-025-02286-5An internation

Updated on:December 26,2025

Dramatic drop in HIV-infected immune cells occurs in patient who received cancer treatment

byJohns Hopkins University School of MedicineScanning electron micrograph showing HIV (yellow) attacking a human T cell (blue). In a new study, Johns Hopkins Medicine-led researchers report on a perso

Updated on: December 26,2025

Dramatic drop in HIV-infected immune cells occurs in patient who received cancer treatment

byJohns Hopkins University School of MedicineScanning electron micrograph showing HIV (yellow) attacking a human T cell (blue). In a new study, Johns Hopkins Medicine-led researchers report on a perso

Updated on:December 26,2025

Early HIV drugs give immune system a brief reprieve before dysregulation returns, study finds

byAmsterdam University Medical CentersCredit: Pixabay/CC0 Public DomainDespite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.Researchers at Amsterda

Updated on: December 26,2025

Early HIV drugs give immune system a brief reprieve before dysregulation returns, study finds

byAmsterdam University Medical CentersCredit: Pixabay/CC0 Public DomainDespite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.Researchers at Amsterda

Updated on:December 26,2025

Early HIV treatment: Research reveals critical gaps

byThe City University of New YorkCredit: Unsplash/CC0 Public DomainIn an articlepublishedinThe Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim

Updated on: December 26,2025

Early HIV treatment: Research reveals critical gaps

byThe City University of New YorkCredit: Unsplash/CC0 Public DomainIn an articlepublishedinThe Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim

Updated on:December 26,2025